Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hansmann

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
Oncoimmunology|July 30, 2016
Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cellsBenjamin Rengstl, Frederike Schmid, Christian Weiser, et al.
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2015
Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosusWilliam E O'Gorman, Elena W Y Hsieh, Erica S Savig, et al.
British Journal of Haematology|October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locusSylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphomaAndreas Josting, Horst Müller, Peter Borchmann, et al.
Journal for Immunotherapy of Cancer|May 2, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoireLeonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.
Cell Cycle (Georgetown, Tex.)|June 22, 2007
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex proteinShirley K Knauer, Carolin Bier, Peter Schlag, et al.
Breast Cancer Research : BCR|February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerCarsten Denkert, Jens Huober, Sibylle Loibl, et al.
Leukemia|May 22, 2025
Common origin and somatic mutation patterns of composite lymphomas and leukemiasVictoria Berg, Anna Lollies, Markus Schneider, et al.
British Journal of Haematology|August 14, 2019
The impact of SOCS1 mutations in diffuse large B-cell lymphomaKevin Mellert, Melanie Martin, Jochen K Lennerz, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Oncoimmunology|July 30, 2016
Tumor-infiltrating HLA-matched CD4(+) T cells retargeted against Hodgkin and Reed-Sternberg cellsBenjamin Rengstl, Frederike Schmid, Christian Weiser, et al.
Blood|October 9, 2013
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2015
Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosusWilliam E O'Gorman, Elena W Y Hsieh, Erica S Savig, et al.
British Journal of Haematology|October 30, 2009
High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locusSylvia Hartmann, Stefan Gesk, René Scholtysik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2010
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphomaAndreas Josting, Horst Müller, Peter Borchmann, et al.
Journal for Immunotherapy of Cancer|May 2, 2025
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoireLeonie Rosenberger, Leo Hansmann, Vasiliki Anastasopoulou, et al.
Cell Cycle (Georgetown, Tex.)|June 22, 2007
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex proteinShirley K Knauer, Carolin Bier, Peter Schlag, et al.
Breast Cancer Research : BCR|February 9, 2013
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerCarsten Denkert, Jens Huober, Sibylle Loibl, et al.
Leukemia|May 22, 2025
Common origin and somatic mutation patterns of composite lymphomas and leukemiasVictoria Berg, Anna Lollies, Markus Schneider, et al.
British Journal of Haematology|August 14, 2019
The impact of SOCS1 mutations in diffuse large B-cell lymphomaKevin Mellert, Melanie Martin, Jochen K Lennerz, et al.
Pageof 26